Revive Therapeutics Reports Grant of Options
TORONTO, ON / ACCESS Newswire / August 14, 2026 / Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(Frankfurt:31R), a life...
TORONTO, ON / ACCESS Newswire / August 14, 2026 / Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(Frankfurt:31R), a life...
TAMPA, FL / ACCESS Newswire / August 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"),...
Toronto, Ontario--(Newsfile Corp. - August 14, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") is...
WINNIPEG, MB / ACCESS Newswire / August 14, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company...
The article explores how combining different approaches to care may support both immediate treatment and long-term wellness.LAMESA, Texas, Aug. 14,...
DELRAY BEACH, Fla., Aug. 14, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the global smart hospital market is projected to reach USD...
AI-Native Remote Patient Monitoring Service Combines Connected Devices, Intelligent Automation, and Clinical Services to Help Health Systems Scale Virtual CareORLANDO,...
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Aug. 14, 2026 /PRNewswire/ -- The New York...
Key opportunities include: managing GLP-1s, encouraging biosimilar substitution and employing technology to simplify and personalize the member experience WOONSOCKET, RI...
NORTHAMPTON, MA / ACCESS Newswire / August 14, 2026 / With more than 90,000 people in the U.S. on the...
Q2 2026 Reported Revenue of $6.6 Million, a 445% Increase Compared to Q2 2025Adjusted EBITDA (non-GAAP) Loss Reduced to $0.6...
Mipletamig Drives Clinical Momentum with Strong Frontline AML Data, Path Toward Phase 2Chief Scientific Officer Appointment Strengthens Execution Across Advancing...
Filament Health's patented, naturally derived psilocybin drug candidate PEX010 will be supplied to PSI-PARK, an investigator initiated randomized clinical trial...
Zoom conference call scheduled for August 18, 2026, at 9:00 AM ETREHOVOT, Israel, Aug. 14, 2026 /PRNewswire/ -- Evogene Ltd....
Introducing a New Model for Co-Creation with ResearchersTOKYO, Aug. 14, 2026 /PRNewswire/ -- Kirin Holdings Company, Limited (Kirin Holdings) and...
SOUTH SAN FRANCISCO, CA / ACCESS Newswire / August 14, 2026 / CASI Pharmaceuticals, Inc. (OTCQB:CASIF), a clinical-stage biopharmaceutical company...
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - August 14, 2026) - Cosmo N.V. (SIX: COPN) (FSE:...